Further research into the complex regulatory mechanisms of the SHH pathway holds the potential to unveil novel therapeutic strategies that can specifically target and suppress this pathway, ultimately leading to improved treatment options for HCC patients. Here, SHH is linked to hepatocellular carcinoma.